These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 29513728)
1. Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma. Ma C; Zhang W; Wu Q; Liu Y; Wang C; Lao G; Yang L; Liu P PLoS One; 2018; 13(3):e0193625. PubMed ID: 29513728 [TBL] [Abstract][Full Text] [Related]
2. Identifying a new microRNA signature as a prognostic biomarker in colon cancer. Lv Y; Duanmu J; Fu X; Li T; Jiang Q PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961 [TBL] [Abstract][Full Text] [Related]
3. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data. Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365 [TBL] [Abstract][Full Text] [Related]
4. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma. Gao X; Wu Y; Yu W; Li H Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas. Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839 [TBL] [Abstract][Full Text] [Related]
6. Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma. Xin X; Zhang Y; Ling F; Wang L; Sheng X; Qin L; Zhao X Exp Eye Res; 2019 Mar; 180():242-249. PubMed ID: 30615885 [TBL] [Abstract][Full Text] [Related]
7. hsa-mir-3199-2 and hsa-mir-1293 as Novel Prognostic Biomarkers of Papillary Renal Cell Carcinoma by COX Ratio Risk Regression Model Screening. Luo W; Wang L; Luo MH; Huang YZ; Yang H; Zhou Y; Jia HT; Wang XX J Cell Biochem; 2017 Oct; 118(10):3488-3494. PubMed ID: 28338236 [TBL] [Abstract][Full Text] [Related]
8. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
9. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer. Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G Gene; 2019 May; 697():86-93. PubMed ID: 30779946 [TBL] [Abstract][Full Text] [Related]
10. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients. Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466 [TBL] [Abstract][Full Text] [Related]
11. Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma. Zhang J; Bing Z; Yan P; Tian J; Shi X; Wang Y; Yang K J Gene Med; 2019 Aug; 21(8):e3105. PubMed ID: 31215090 [TBL] [Abstract][Full Text] [Related]
12. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC. Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396 [TBL] [Abstract][Full Text] [Related]
13. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma. Zhang J; Chong CC; Chen GG; Lai PB PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing. Lin W; Feng M; Chen G; Zhou Z; Li J; Ye Y Oncol Rep; 2017 Mar; 37(3):1477-1486. PubMed ID: 28098890 [TBL] [Abstract][Full Text] [Related]
15. Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma. Zhang L; Xiang P; Han X; Wu L; Li X; Xiong Z Int J Clin Exp Pathol; 2015; 8(9):11446-51. PubMed ID: 26617873 [TBL] [Abstract][Full Text] [Related]
16. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer. Wang XJ; Zeng B; Lin S; Chen M; Chi P Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423 [TBL] [Abstract][Full Text] [Related]
17. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer. Zeng Y; Wang KX; Xu H; Hong Y J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797 [TBL] [Abstract][Full Text] [Related]
18. Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma. Yu J; Zhu M; Lv M; Wu X; Zhang X; Zhang Y; Li J; Zhang Q Sci Rep; 2019 Dec; 9(1):19847. PubMed ID: 31882677 [TBL] [Abstract][Full Text] [Related]
19. A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma. Qin R; Cao L; Ye C; Wang J; Sun Z BMC Med Genomics; 2021 Feb; 14(1):49. PubMed ID: 33588862 [TBL] [Abstract][Full Text] [Related]
20. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer. Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]